Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

This #GivingTuesday, whatever is your first priority, your second priority has to be independent media.

2021 has been one of the most dangerous and difficult years for independent journalism that we’ve ever seen. Our democracy is facing serial existential threats including the climate emergency, vaccine apartheid amid deadly pandemic, a global crisis for biodiversity, reproductive freedoms under assault, rising authoritarianism worldwide, and corporate-funded corruption of democracy that run beneath all of this. Giving Tuesday is a critical opportunity to make sure our journalism remains funded so that we can stay focused on all your priority issues. Please contribute today to keep Common Dreams alive and growing.

Please Help This #GivingTuesday -- Though our content is free to all, less than 1% of our readers give. We’re counting on you. Please help Common Dreams end the year strong.

For Immediate Release


Phone: (202) 588-1000

Press Release

60+ Groups Demand Schumer, Pelosi Not Cave To Big Pharma, Include Medicare Expansion in Build Back Better Package


More than 60 national, state and local groups today sent a letter to Senate Majority Leader Chuck Schumer and Speaker of the House Nancy Pelosi, urging the Democratic leaders to resist demands from some caucus members seeking to weaken the Medicare drug price negotiation policies in the Build Back Better Act.

“There are few issues of greater salience to people across this country than lowering drug prices, and few policies more common sense and popular than Medicare drug price negotiation,” said Steve Knievel, an advocate for Public Citizen’s Access to Medicines program. “Leader Schumer and Speaker Pelosi know this, and it is why they have promised it for years. Now it is time to deliver.”

The groups, including Public Citizen, Indivisible, People’s Action and Social Security Works, contended that weakening this popular policy would leave campaign promises unfulfilled and allow Big Pharma to continue to price gouge and profiteer from exorbitantly high drug prices. A recent Public Citizen report found that for top drugs, Big Pharma received twice as much revenue from the U.S. than from the rest of the world combined. Some Democratic caucus members, including U.S. Reps. Scott Peters (D-Calif.), Kurt Schrader (D-Ore.) and Kathleen Rice (D-N.Y.), have proposed changes that would render price negotiations virtually meaningless by excluding patented drugs from negotiations and removing the excise tax penalty to enforce drug corporation participation.

“We stand with you to fulfill your long-standing promises to pass drug price negotiation and bold drug pricing reform, and to finally deliver on years of promises to enact one of the most common sense and popular measures ever demanded of Congress,” the letter said.

The letter follows a similar letter to Democratic leadership from 77 organizations, urging the inclusion of Medicare drug price negotiation and Medicare expansion in the Democrats’ reconciliation package.

Read the full letter here.


Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people – not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.

Omar Hangs Up After Boebert Uses Call to Double Down on 'Outright Bigotry and Hate'

"Instead of apologizing for her Islamophobic comments and fabricated lies, Rep. Boebert refused to publicly acknowledge her hurtful and dangerous comments."

Jessica Corbett ·

Win for Alabama Workers as NLRB Orders New Union Vote After Amazon's Alleged Misconduct

A union leader said the decision confirmed that "Amazon's intimidation and interference prevented workers from having a fair say in whether they wanted a union in their workplace."

Jessica Corbett ·

'For the Sake of Peace,' Anti-War Groups Demand Biden Return to Nuclear Deal With Iran

"It's time to put differences aside and return to the Iran nuclear deal," said one advocate.

Julia Conley ·

'That's for Them to Decide': UK Secretary Rebuked for Claiming Vaccine Patent Waiver Won't Be 'Helpful' to Global Poor

One U.K. lawmaker asked when the government would "start putting the need to end this pandemic in front of the financial interests of Big Pharma?"

Andrea Germanos ·

Shell Slammed for Plan to Blast South African Coastline for Oil and Gas During Whale Season

"We cannot allow climate criminals, like Shell, to plunder in the name of greed," said Greenpeace.

Kenny Stancil ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.

Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo